Is a complete SCTX research report available?

No complete published report is available for Scribe Therapeutics Inc. (SCTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Scribe Therapeutics Inc. (SCTX)

NASDAQ: SCTX · USD

$20.4

+2.04 (+11.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SCTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	384.8M
Revenue (ttm)	36.3M
Net income (ttm)	-35.7M
EPS (ttm)	-$14.6
Shares out	18.9M
Volume	149,195

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.3M
Net income (ttm): -35.7M
EPS (ttm): -$14.6
Market cap: 384.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SCTX indicators

Market & fundamental data

Available fields

142

Groups with data

Currency

USD

Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001853921
Company name	Scribe Therapeutics Inc.
Country	United States
Country code	US
Cusip	811033109
Employees	89
Employees Change	0%
Employees Change Percent	0
Enterprise value	$381.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-25
Industry	Biotechnology
IPO Date	2026-07-24
Isin	US8110331092
Last refreshed	2026-07-31
Market cap	$384.8M
Market cap category	Small-Cap
Price	$20.4
Price currency	USD
Rev Per Employee	407,662.92x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	SCTX
Website	https://www.scribetx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.28%
EV/Sales	10.51x
FCF yield	-10.38%
P/S ratio	10.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-90.79%
EBITDA Margin	-82.62%
Gross margin	-54.65%
Gross Profit	$-19.8M
Net Income	$-35.7M
Net Income Growth Years	1%
Pretax Margin	-101.95%
Profit Margin	-98.48%
Profit Per Employee	$-401,461
ROCE	227

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	1
Revenue Growth	86.68x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$65.2M
Cash	$49.7M
Current Assets	$52.4M
Current Liabilities	$79.7M
Debt	$46.3M
Equity	$-38.4M
Interest Coverage	-13.77
Liabilities	$103.6M
Long Term Assets	$12.8M
Long Term Liabilities	$23.9M
Net Cash	$3.4M
Net Cash By Market Cap	$0.88
Tangible Book Value	$-158.7M
Tangible Book Value Per Share	$-64.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.66
Net Working Capital	$-35.2M
Quick ratio	0.64
Working Capital	$-27.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	25.49
All Time High Change	-19.97%
All Time High Date	2026-07-24
All Time Low	17.31
All Time Low Change	17.89%
All Time Low Date	2026-07-27
High	22.66
High52	25.49
High52 Date	2026-07-24
High52ch	-19.97%
Low	18.67
Low52	17.31
Low52 Date	2026-07-27
Low52ch	17.89%
Premarket Change Percent	7.95
Premarket Price	$19.82
Premarket Volume	1,133
RSI	0
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-2.06x
Sortino ratio	-2.63

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-32.9M
Operating margin	-90.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,957,273%
Float Percent	47.48%
Shares Insiders	8.83%
Shares Out	18,864,386
Shares Qo Q	1.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-45.4M
Adjusted OCF	-44,590,000
Average Volume	462,314.8x
Bv Per Share	-64.31
CAPEX	$-797,000
Change	11.11%
Change From Open	8.57
Close	18.36
Days Gap	2.34
Depreciation Amortization	2,963,000
Dollar Volume	3,043,578
Earnings Date	2026-08-29
Earnings Time	amc
EBIT	$-32.9M
EBITDA	$-30M
EPS	$-14.64
F Score	0
FCF	$-39.9M
FCF EV Yield	-10.47x
FCF Per Share	$-2.12
Financing CF	-267,000
Fiscal Year End	December
Founded	2,017
Income Tax	$-1.3M
Investing CF	39,898,000
Ipr	36
Iprfo	-18.4
Is Primary Listing	1
Is Spac	No
Last Report Date	2026-03-31
Last Split Type	Never
Net CF	484,000
Next Earnings Date	2026-08-29
Open	18.79
Position In Range	43.36
Post Close	20.4
Postmarket Change Percent	5.44
Postmarket Price	$21.51
Ppne	9,316,000
Pre Close	18.36
Price Date	2026-07-30
Relative Volume	0.32x
Revenue	36,282,000x
SBC By Revenue	15x
Share Based Comp	5,443,000
Tax By Revenue	-3.47x
Us State	California
Views	176
Volume	149,195
Z Score	-5.37

Scribe Therapeutics Inc. (SCTX)

Coverage state: Market snapshot only — no published research

Generate the first SCTX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SCTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SCTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SCTX

Frequently asked questions